DLA Piper, Nabarro and King & Wood Mallesons (KWM) are among the firms that have advised a clutch of pharmaceutical companies, including GlaxoSmithKline (GSK), as they were fined £45m. 

GSK has been fined alongside a raft of other pharmaceutical firms for paying rival drug makers to delay the release of their competing drugs into the UK marketplace between 2001 and 2004.